vs
DigitalOcean Holdings, Inc.（DOCN）与VERACYTE, INC.（VCYT）财务数据对比。点击上方公司名可切换其他公司
DigitalOcean Holdings, Inc.的季度营收约是VERACYTE, INC.的1.7倍（$242.4M vs $140.6M），VERACYTE, INC.净利率更高（29.3% vs 10.6%，领先18.7%），VERACYTE, INC.同比增速更快（18.5% vs 18.3%），VERACYTE, INC.自由现金流更多（$48.8M vs $31.1M），过去两年VERACYTE, INC.的营收复合增速更高（20.5% vs 14.5%）
DigitalOcean Holdings, Inc.是美国跨国科技企业及云服务提供商，总部位于美国科罗拉多州布鲁姆菲尔德，在全球布局15个数据中心，面向开发者、初创企业及中小微企业提供稳定易用的云基础设施即服务平台，助力各类技术团队高效开展业务。
Veracyte是一家领先的分子诊断企业，专注开发专有的基因组检测方案，可实现癌症及其他复杂疾病的早期精准检测，产品服务于医疗机构以优化临床决策，核心市场位于美国，正稳步拓展全球业务布局。
DOCN vs VCYT — 直观对比
营收规模更大
DOCN
是对方的1.7倍
$140.6M
营收增速更快
VCYT
高出0.3%
18.3%
净利率更高
VCYT
高出18.7%
10.6%
自由现金流更多
VCYT
多$17.7M
$31.1M
两年增速更快
VCYT
近两年复合增速
14.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $242.4M | $140.6M |
| 净利润 | $25.7M | $41.1M |
| 毛利率 | 58.7% | 72.5% |
| 营业利润率 | 16.0% | 26.4% |
| 净利率 | 10.6% | 29.3% |
| 营收同比 | 18.3% | 18.5% |
| 净利润同比 | 40.5% | 704.8% |
| 每股收益（稀释后） | $0.23 | $0.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCNVCYT
| Q4 25 | $242.4M | $140.6M | ||
| Q3 25 | $229.6M | $131.9M | ||
| Q2 25 | $218.7M | $130.2M | ||
| Q1 25 | $210.7M | $114.5M | ||
| Q4 24 | $204.9M | $118.6M | ||
| Q3 24 | $198.5M | $115.9M | ||
| Q2 24 | $192.5M | $114.4M | ||
| Q1 24 | $184.7M | $96.8M |
净利润DOCNVCYT
| Q4 25 | $25.7M | $41.1M | ||
| Q3 25 | $158.4M | $19.1M | ||
| Q2 25 | $37.0M | $-980.0K | ||
| Q1 25 | $38.2M | $7.0M | ||
| Q4 24 | $18.3M | $5.1M | ||
| Q3 24 | $32.9M | $15.2M | ||
| Q2 24 | $19.1M | $5.7M | ||
| Q1 24 | $14.1M | $-1.9M |
毛利率DOCNVCYT
| Q4 25 | 58.7% | 72.5% | ||
| Q3 25 | 59.6% | 69.2% | ||
| Q2 25 | 59.9% | 69.0% | ||
| Q1 25 | 61.4% | 69.5% | ||
| Q4 24 | 57.1% | 66.4% | ||
| Q3 24 | 60.2% | 68.2% | ||
| Q2 24 | 61.0% | 68.1% | ||
| Q1 24 | 60.7% | 64.5% |
营业利润率DOCNVCYT
| Q4 25 | 16.0% | 26.4% | ||
| Q3 25 | 19.6% | 17.4% | ||
| Q2 25 | 16.3% | -4.0% | ||
| Q1 25 | 17.9% | 2.5% | ||
| Q4 24 | 15.9% | 3.5% | ||
| Q3 24 | 12.4% | 10.4% | ||
| Q2 24 | 11.6% | 4.0% | ||
| Q1 24 | 6.2% | -4.8% |
净利率DOCNVCYT
| Q4 25 | 10.6% | 29.3% | ||
| Q3 25 | 69.0% | 14.5% | ||
| Q2 25 | 16.9% | -0.8% | ||
| Q1 25 | 18.1% | 6.2% | ||
| Q4 24 | 8.9% | 4.3% | ||
| Q3 24 | 16.6% | 13.1% | ||
| Q2 24 | 9.9% | 5.0% | ||
| Q1 24 | 7.7% | -1.9% |
每股收益（稀释后）DOCNVCYT
| Q4 25 | $0.23 | $0.50 | ||
| Q3 25 | $1.51 | $0.24 | ||
| Q2 25 | $0.39 | $-0.01 | ||
| Q1 25 | $0.39 | $0.09 | ||
| Q4 24 | $0.21 | $0.07 | ||
| Q3 24 | $0.33 | $0.19 | ||
| Q2 24 | $0.20 | $0.07 | ||
| Q1 24 | $0.15 | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $254.5M | $362.6M |
| 总债务越低越好 | $1.3B | — |
| 股东权益账面价值 | $-28.7M | $1.3B |
| 总资产 | $1.8B | $1.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DOCNVCYT
| Q4 25 | $254.5M | $362.6M | ||
| Q3 25 | $236.6M | $315.6M | ||
| Q2 25 | $387.7M | $219.5M | ||
| Q1 25 | $360.4M | $186.1M | ||
| Q4 24 | $428.4M | $239.1M | ||
| Q3 24 | $439.9M | $274.1M | ||
| Q2 24 | $443.1M | $235.9M | ||
| Q1 24 | $419.1M | $209.2M |
总债务DOCNVCYT
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益DOCNVCYT
| Q4 25 | $-28.7M | $1.3B | ||
| Q3 25 | $-69.6M | $1.3B | ||
| Q2 25 | $-175.2M | $1.2B | ||
| Q1 25 | $-210.7M | $1.2B | ||
| Q4 24 | $-203.0M | $1.2B | ||
| Q3 24 | $-211.7M | $1.2B | ||
| Q2 24 | $-253.8M | $1.1B | ||
| Q1 24 | $-286.1M | $1.1B |
总资产DOCNVCYT
| Q4 25 | $1.8B | $1.4B | ||
| Q3 25 | $1.7B | $1.4B | ||
| Q2 25 | $1.7B | $1.3B | ||
| Q1 25 | $1.6B | $1.3B | ||
| Q4 24 | $1.6B | $1.3B | ||
| Q3 24 | $1.5B | $1.3B | ||
| Q2 24 | $1.5B | $1.2B | ||
| Q1 24 | $1.5B | $1.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $57.3M | $52.6M |
| 自由现金流经营现金流 - 资本支出 | $31.1M | $48.8M |
| 自由现金流率自由现金流/营收 | 12.8% | 34.7% |
| 资本支出强度资本支出/营收 | 10.8% | 2.7% |
| 现金转化率经营现金流/净利润 | 2.23× | 1.28× |
| 过去12个月自由现金流最近4个季度 | $180.5M | $126.6M |
8季度趋势，按日历期对齐
经营现金流DOCNVCYT
| Q4 25 | $57.3M | $52.6M | ||
| Q3 25 | $95.8M | $44.8M | ||
| Q2 25 | $92.4M | $33.6M | ||
| Q1 25 | $64.1M | $5.4M | ||
| Q4 24 | $71.3M | $24.5M | ||
| Q3 24 | $73.4M | $30.0M | ||
| Q2 24 | $71.3M | $29.6M | ||
| Q1 24 | $66.7M | $-9.0M |
自由现金流DOCNVCYT
| Q4 25 | $31.1M | $48.8M | ||
| Q3 25 | $88.0M | $42.0M | ||
| Q2 25 | $59.3M | $32.3M | ||
| Q1 25 | $2.1M | $3.5M | ||
| Q4 24 | $26.1M | $20.4M | ||
| Q3 24 | $16.0M | $27.7M | ||
| Q2 24 | $39.5M | $26.8M | ||
| Q1 24 | $23.0M | $-11.1M |
自由现金流率DOCNVCYT
| Q4 25 | 12.8% | 34.7% | ||
| Q3 25 | 38.3% | 31.8% | ||
| Q2 25 | 27.1% | 24.8% | ||
| Q1 25 | 1.0% | 3.1% | ||
| Q4 24 | 12.7% | 17.2% | ||
| Q3 24 | 8.1% | 23.9% | ||
| Q2 24 | 20.5% | 23.4% | ||
| Q1 24 | 12.5% | -11.5% |
资本支出强度DOCNVCYT
| Q4 25 | 10.8% | 2.7% | ||
| Q3 25 | 3.4% | 2.1% | ||
| Q2 25 | 15.2% | 1.0% | ||
| Q1 25 | 29.4% | 1.6% | ||
| Q4 24 | 22.1% | 3.5% | ||
| Q3 24 | 28.9% | 1.9% | ||
| Q2 24 | 16.6% | 2.4% | ||
| Q1 24 | 23.6% | 2.2% |
现金转化率DOCNVCYT
| Q4 25 | 2.23× | 1.28× | ||
| Q3 25 | 0.60× | 2.34× | ||
| Q2 25 | 2.50× | — | ||
| Q1 25 | 1.68× | 0.76× | ||
| Q4 24 | 3.91× | 4.80× | ||
| Q3 24 | 2.23× | 1.98× | ||
| Q2 24 | 3.73× | 5.16× | ||
| Q1 24 | 4.72× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOCN
| Scalers | $84.3M | 35% |
| Scalers Plus | $69.9M | 29% |
| Builders | $64.1M | 26% |
| Learners Testers And Other | $24.1M | 10% |
VCYT
| Testing | $135.8M | 97% |
| Products | $3.8M | 3% |
| Biopharmaceutical And Other | $686.0K | 0% |
